Ultragenyx Pharma (RARE) Misses Q4 EPS by 45c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 16.78 -0.42 (2.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.20 | 52 Week High | $117.12 | |||
| Open | $17.26 | 52 Week Low | $46.52 | |||
| Day High | $17.63 | P/E | N/A | |||
| Day Low | $16.71 | EPS | $-1.97 | |||
| Volume | 2,803,713 | |||||
